Company: LICN
Filing Date: 2025-01-29
Form Type: 424B5
Source: 0001213900-25-007741
Chunk: 0

Company: Lichen International Ltd
Filing Date: 2025-01-29
Form: 424B5
Chunk 0
---
Filed pursuant to Rule 424(b)(5)

Registration No. 333-277230

Prospectus Supplement

(To Prospectus dated March 1, 2024)

<div align='center'>20,933,333 Class A Ordinary Shares
Pre-Funded Warrants to Purchase up to 21,566,667 Class A Ordinary Shares
Up to 21,566,667 Class A Ordinary Shares issuable upon exercise of Pre-Funded Warrants

Lichen China Limited</div>

This is an offering of the securities
of Lichen China Limited (the “Company”, “we”, “our”, “us”, “Lichen China”,
“Lichen China Limited”), a Cayman Islands exempted company with limited liability.

Our Class A ordinary shares are listed on The
Nasdaq Capital Market, or Nasdaq, under the symbol “LICN.” On January 28, 2025, the last reported sale price of our Class
A ordinary shares on Nasdaq was US$0.091 per share.

This prospectus supplement and the accompanying
base prospectus relates to an offering of an aggregate of (i) 20,933,333 Class A ordinary shares (the “Shares”) of the Company,
par value $0.00004 per share and (ii) pre-funded warrants (the “Pre-Funded Warrants”) to purchase an aggregate of up to 21,566,667
Class A ordinary shares (and the shares that are issuable from time to time upon exercise of the Pre-Funded Warrants (the “Pre-Funded
Warrant Shares”)), pursuant to a Securities Purchase Agreement, dated as of January 28, 2025, between the Company and the purchasers
identified on the signature pages thereto. The purchase price of each Share is $0.08.

We have retained Univest Securities, LLC (the
“Placement Agent” or “Univest”) as our placement agent to use its “reasonable best efforts” to solicit
offers to purchase our shares in this offering. The Placement Agent has no obligation to buy any of the securities from us or to arrange
for the purchase or sale of any specific number or dollar amount of securities.

We will pay all of the expenses incident to the
registration, offering and sale of the shares and the Pre-Funded Warrants under this prospectus supplement and the accompanying base prospectus.

The aggregate market value of our outstanding Class A ordinary shares
held by non-affiliates, or public